Contribution of common plastic-related endocrine disruptors to epithelial-mesenchymal transition (EMT) and tumor progression - ScienceDirect
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
Currently available serum and tissue markers for liver cancer. | Download Table
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples | BMC Cancer
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Inflammation: the incubator of the tumor microenvironment: Trends in Cancer
Deciphering cancer clues from blood | Science
Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy: Molecular Therapy - Oncolytics
The significance of elevated tumor markers among patients with interstitial lung diseases | Scientific Reports
The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study - Tong - 2018 - Cancer Medicine - Wiley Online Library
Original Article Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma
![Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13488/1/fig-2-2x.jpg "Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study [PeerJ]")
Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study [PeerJ]
Frontiers | Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models
Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. - Abstract - Europe PMC
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies | Nature Reviews Urology
DRH1 – a novel blood-based HPV tumour marker - eBioMedicine
Is cancer biology different in older patients? - The Lancet Healthy Longevity
Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker. | Semantic Scholar
